ReviewDrugs2010
Anaerobic infections: update on treatment considerations.
Review in Drugs, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 107 citations in OpenAlex.
- Clinical Picture and Outcomes in Patients Diagnosed with Brain Abscess.Journal of clinical medicine · 2025Article
- A Comprehensive Investigation on Catalytic Behavior of Anaerobic Jar Gassing Systems and Design of an Enhanced Cultivation System.Bioengineering (Basel, Switzerland) · 2024Article
- Detection of the antibiotic resistance genes content of intestinal Bacteroides, Parabacteroides and Phocaeicola isolates from healthy and carbapenem-treated patients from European countries.BMC microbiology · 2024Article
- Gut microbiome, T cell subsets, and cytokine analysis identify differential biomarkers in tuberculosis.Frontiers in immunology · 2024Article
- Targeting the 16S rRNA Gene by Reverse Complement PCR Next-Generation Sequencing: Specific and Sensitive Detection and Identification of Microbes Directly in Clinical Samples.Microbiology spectrum · 2023Article
- Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19.Gut pathogens · 2023Article
- Antimicrobial Susceptibility Profile of Rare Anaerobic Bacteria.Antibiotics (Basel, Switzerland) · 2022Article
- Femoral osteomyelitis caused by oral anaerobic bacteria with mixed bacteremia of Campylobacter rectus and Parvimonas micra in a chronic periodontitis patient: a case report.BMC infectious diseases · 2022Article
- In Vitro Efficacy of Antibiotic Combinations with Carbapenems and Other Agents against Anaerobic Bacteria.Antibiotics (Basel, Switzerland) · 2022Article
- Distribution of anaerobic bacteria and their sensitivity pattern to several antibiotics at the clinical microbiology laboratory of school of medicine, universitas Indonesia, Jakarta in 2019-2020.Iranian journal of microbiology · 2022Article
- A challenging case of thoracic empyema caused byRespiratory medicine case reports · 2022Article
- Prevotella diversity, niches and interactions with the human host.Nature reviews. Microbiology · 2021Review
- In Vitro Antimicrobial Susceptibility Profiles of Gram-Positive Anaerobic Cocci Responsible for Human Invasive Infections.Microorganisms · 2021Article
- Synbiotics Supplements Lower the Risk of Hand, Foot, and Mouth Disease in Children, Potentially by Providing Resistance to Gut Microbiota Dysbiosis.Frontiers in cellular and infection microbiology · 2021Article
- Nasopharyngeal Microbial Communities of Patients Infected With SARS-CoV-2 That Developed COVID-19.Frontiers in microbiology · 2021Article
- Oxygen and Metabolism: Digesting Determinants of Antibiotic Susceptibility in the Gut.iScience · 2020Review
- Antimicrobial Susceptibility Patterns and Wild-Type MIC Distributions of Anaerobic Bacteria at a German University Hospital: A Five-Year Retrospective Study (2015-2019).Antibiotics (Basel, Switzerland) · 2020Article
- The Pathogenic Role ofAntibiotics (Basel, Switzerland) · 2020Review
- Nonpuerperal breast abscess due toClinical case reports · 2020Article
- Relevance of anaerobic bacteremia in adult patients: A never-ending story?European journal of microbiology & immunology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anaerobic bacteria are the predominant indigenous flora of humans and, as a result, play an important role in infections, some of which are serious with a high mortality rate. These opportunistic pathogens are frequently missed in cultures of clinical samples because of shortcomings in collection and transport procedures as well as lack of isolation and susceptibility testing of anaerobes in many clinical microbiology laboratories. Correlation of clinical failures with known antibacterial resistance of anaerobic bacteria is seldom possible. Changes in resistance over time, and the discovery and characterization of resistance determinants in anaerobic bacteria, has increased recognition of problems in empirical treatment and has even resulted in changes in treatment guidelines. This review discusses the role of anaerobic bacteria in the normal flora of humans, their involvement in different mixed infections, developments in antibacterial resistance of the most frequent anaerobic pathogens and possible new treatment options.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.